Media Pack
News

Current Edition

Volume 16 Issue 1
 
Regional News

Teligent, Edge Pharma yank meds on superpotency, sterility concerns

Sterility concerns and out-of-spec testing results are two common sources of drug recalls. Now, the problems have hit two drugmakers at once. For one of the companies...
13 December 2021 Regional News compounding | drug recall
Continue Reading →
Regional News

AbbVie’s Rinvoq, Pfizer’s Xeljanz and Lilly’s Olumiant slapped with new FDA warnings amid JAK safety crackdown

The second regulatory shoe has finally dropped for AbbVie, Pfizer and Eli Lilly amid the safety review of JAK inhibitors for inflammatory diseases. But confirmed labe...
8 December 2021 Regional News AbbVie | atopic dermatitis
Continue Reading →
Regional News

Bristol Myers Squibb’s next-gen autoimmune med starts high-stakes FDA review amid classwide JAK scrutiny

After the FDA slapped an updated safety warning on marketed oral JAK inhibitors for inflammatory diseases, market watchers have started worrying about other candidate...
1 December 2021 Regional News Autoimmune Diseases | Bristol Myers Squibb
Continue Reading →
Regional News

Sagent Pharmaceuticals recalls injectable seizure med thanks to familiar packaging glitch

A familiar packaging snafu has led to another recall at Nichi-Iko Group's Sagent Pharmaceuticals. The Illinois-based manufacturer is recalling four lots of injectabl...
24 November 2021 Regional News drug recall | packaging
Continue Reading →
 
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte